Bio-Path Holdings, Inc.
(NASDAQ : BPTH)

( )
BPTH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.02%384.210.0%$5285.71m
BNTXBioNTech SE -9.96%276.520.0%$899.27m
NVAXNovavax, Inc. -11.34%204.8379.4%$857.11m
SNSSSunesis Pharmaceuticals, Inc. -5.26%7.930.7%$554.34m
AMGNAmgen, Inc. -0.39%212.271.4%$540.36m
GILDGilead Sciences, Inc. -0.63%69.971.0%$446.95m
REGNRegeneron Pharmaceuticals, Inc. -2.27%605.002.7%$428.21m
ILMNIllumina, Inc. -3.61%410.203.5%$346.87m
BIIBBiogen, Inc. -0.67%284.711.7%$303.41m
VRTXVertex Pharmaceuticals, Inc. -0.99%181.601.9%$247.39m
ISEEIVERIC bio, Inc. -10.97%15.580.0%$187.66m
LIFEaTyr Pharma, Inc. -1.41%9.762.1%$149.96m
BGNEBeiGene Ltd. -3.55%363.801.3%$141.01m
TECHBio-Techne Corp. -4.42%488.874.5%$131.91m
KDMNKadmon Holdings, Inc. -0.45%8.800.8%$129.86m

Company Profile

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.